These correlations of LAMP2 expression with various clinicopathological features highlight that more attention should be paid to the patients with certain concomitant clinical traits, such as an age over 60 years, the absence of Barrett’s esophagus, or distal central location of the tumor. This evidence concerns the gene LAMP2 and esophageal adenocarcinoma.